In a recent quarterly report, Moody’s Investors Service called out hospital labor shortages as having a potential material impact on procedures in 2022, even as the omicron surge begins to decline.
The second-largest player slashed its MA growth forecast for the year as startup insurtechs report membership gains.
People flocked to get booster shots as the omicron variant drove a sharp increase in testing, boosting revenue for CVS’ drugstore segment. Meanwhile, its payer arm reported lower-than-expected COVID-19 treatment costs.
The hospital operator plans to buy 30 more centers from SurgCenter Development this year in addition to 16 it already acquired year-to-date, executives said on a earnings call Tuesday.
Along with virtual health services now being available for employers nationwide, Amazon Care is expanding its in-person benefit to 20 more cities this year, the e-commerce giant said Tuesday.
The California hospital system is accused of wielding its market power to drive up health insurance premiums for hundreds of thousands of consumers in the locations where it operates.
The company estimated revenue from its COVID-19 vaccine and new antiviral pill Paxlovid will total $54 billion this year.
The U.S.’s historical legacies of racism and sexism have shaped the employment trajectories of Black women, dating back to how care work was divided in slavery and domestic service, according to new research.
Zimmer Biomet, Stryker and Johnson & Johnson’s businesses endured more pressures tied to the postponement of elective procedures in the fourth quarter, but sales of their robotic systems continued to expand.
While earlier shortages were characterized by staff calling in sick and school closures, stress and burnout now are leading to rising turnover with many healthcare personnel at their breaking points.